Horn & Co. advised Biosight Ltd. in the transaction.
Biosight Ltd. signed a merger agreement with Advaxis, Inc, a clinical-stage biotechnology company.
BioSight is a pharmaceutical development company, developing novel cancer-targeted drugs.
The Horn & Co team was led by Yuval Horn (Picture), Assaf Unger and Ana Eiskov.
Law Firms: Horn & Co. Law;
Clients: Biosight, Ltd;